CD4 and neoplasm: treated osteosarcoma with L19TNF-a (L), marfalan (M), and gemcitabine (G) showed a decrease in Treg cells, myeloid suppressor cells (MDSCs), and a significant increase in CD4+ and CD8+ T cells in tumor tissue (88).